![]() |
市場調查報告書
商品編碼
1372031
2030 年植入式醫療設備市場預測:按產品類型、最終用戶和地區分類的全球分析Implantable Medical Devices Market Forecasts to 2030 - Global Analysis By Product, Type, End User and By Geography |
根據Stratistics MRC的數據,2023年全球植入醫療設備市場規模為1,248億美元,預計2030年將達到2,592億美元,預測期內年複合成長率為11.0%。
醫療植入物是插入皮下或體內的物體或組織。植入物的目的是用人造零件替換缺少的身體部位。植入物可以出於治療、診斷或監測目的而永久插入,也可以在完成其功能後移除。植入物用於身體的許多部位,具有多種用途,包括藥物傳輸系統、神經假體、整形外科、心律調節器、心血管支架和心臟去顫器。植入物透過外科手術或藥物程序全部或部分插入人體。植入式醫療設備的醫療益處包括提高病人安全和生活品質。
據世界衛生組織稱,2022年,美國將記錄5,000萬例癲癇病例、10億例偏頭痛病例和40萬例脊髓損傷病例。
這種方法越來越受歡迎,可以在職場和社交場合增強自信和自尊。人們越來越常採用臉部植入物等美容產品來增強個人的美麗和外觀。此外,臉部植入物主要用於強調或矯正臉部骨骼的不規則性。雖然人們認為形狀優美的下巴可以凸顯男性的吸引力,但女性更喜歡方形下巴,因此下巴矯正對男性和女性都很重要。因此,這些因素對市場擴張產生了有益的影響。
植入式醫療設備的高昂初期成本可能對病患和醫療保健系統構成阻礙力。植入式醫療設備通常涉及高昂的成本,不僅包括設備本身,還包括手術、術後護理、未來設備替換和再次手術的費用。然而,這些費用對許多人來說可能令人望而卻步,特別是如果他們沒有足夠的健康保險或保險。因此,有些患者因為負擔不起而跳過植牙治療。植入式醫療設備的高成本是市場擴張的主要障礙。
由於糖尿病、心血管疾病和神經退化性疾病等慢性病的患病不斷增加,植入式醫療設備的需求量很大。這些疾病可以藉助神經刺激設備、心臟植入物和胰島素幫浦等設備進行管理和治療。此外,植入式醫療設備可以提供長期且永續的解決方案來控制慢性疾病,改善患者的生活品質並減輕持續護理和頻繁醫院就診的壓力。這些要素正在增加市場需求。
設備相容性是植入式醫療設備市場的關鍵障礙,因為很難將植入式醫療設備與患者的個人解剖結構和醫療狀況正確匹配。每個人都有獨特的解剖學和生理學特徵。然而,由於這種可變性,植入式醫療技術必須進行客製化,以滿足每個患者的獨特要求和特徵。當該小工具需要專用佩戴或需要個人化治療時,這個問題變得更加明顯。因此,這是市場需求的障礙。
COVID-19大流行減少了對植入式醫療設備的需求,並增加了醫護人員、助手和接受植入手術的患者交叉感染的風險,導致所有發生該疾病的國家對植入式醫療器械的需求減少起源於大流行期間的常規植入手術被叫停,大大減緩了該行業的擴張。由於 COVID-19 的爆發,植入式醫療設備市場受到了影響。
由於患者對微創手術的需求不斷增加以及全球道路事故和傷害數量不斷增加,預計金屬細分市場將佔據最大佔有率。此外,在整形外科手術中擴大使用金屬植入物來為骨折和關節提供強力的支撐,也有助於這一市場主導地位。因此,隨著世界上越來越多的人患有關節炎,這個市場預計將繼續擴大。
預計整形外科植入物領域將在預測期內出現良好的成長。整形外科植入物在世界各地廣泛用於支撐骨折或取代缺失的骨骼或關節。導致骨折和關節損傷的事故數量不斷增加,推動了這個市場的擴張。此外,類風濕性關節炎的患病正在增加,導致肘關節關節重建的增加。因此,現在正在進行更多的整形外科手術,這可能會在未來年度整形外科植入物的發展。
在估計期間,北美佔據了最大的市場佔有率。現在許多慢性病在北美很常見,老年人的數量也在增加。此外,先進醫療基礎設施的可用性、微創手術的使用增加以及消費者醫療保健支出的增加是預計推動該地區醫療植入物市場成長的主要要素。此外,過去,北美居民對各種醫療植入物的可用性的認知不斷提高,極大地促進了市場的擴張。
由於研發行業的擴張、醫療改革的激增、醫療基礎設施的改善、擁有最先進設施的醫院數量的增加、醫療技術的發展,亞太地區將在領域。預計醫療設備在識別、監測和管理各種疾病方面發揮重要作用,導致對醫療設備的需求不斷成長。該地區與許多著名的醫療設備製造商和研究中心相連。
According to Stratistics MRC, the Global Implantable Medical Devices Market is accounted for $124.8 billion in 2023 and is expected to reach $259.2 billion by 2030 growing at a CAGR of 11.0% during the forecast period. Medical implants are objects or tissues that are inserted beneath the skin or inside the body. The purpose of implants is to replace missing body parts with prostheses. The implants may be inserted permanently for therapeutic, diagnostic, or monitoring purposes, or they may be withdrawn after their function has been met. Implants are utilized in numerous sections of the body for a variety of purposes, including drug delivery systems, neural prosthetics, orthopedics, pacemakers, cardiovascular stents, and defibrillators. Implants are inserted into the human body either fully or partially through surgical or medicinal procedures. Health care benefits from implantable medical devices include increased patient safety and quality of life.
According to the WHO, in 2022, the US recorded 50 million epilepsy cases; 1 billion migraine cases; and 400,000 spinal cord injury cases.
This method is becoming increasingly common in the workplace and during social gatherings that boost one's self-confidence and self-esteem. In order to improve one's beauty and physical appearance, aesthetic products like facial implants are being adopted more frequently. Additionally, facial implants are primarily used to enhance or correct the skeletal concavities and convexities of the face. Both genders are placing more emphasis on jaw correction since a well-defined jaw line is thought to accentuate a man's attractiveness, while an angular jaw line is preferred by women. As a result, these elements are having a beneficial effect on market expansion.
The high initial cost of implantable medical devices can be a deterrent for both patients and healthcare systems. Implantable medical devices frequently carry a hefty price tag that includes not only the cost of the device itself but also costs for the surgery, aftercare, and prospective device replacements or revisions in the future. However, these costs can be very expensive for many people, especially if they don't have proper health insurance or coverage. As a result, some patients could skip implantable treatments because they are unable to pay for them. The high cost of implantable medical devices is a significant barrier to market expansion.
Implantable medical devices are in high demand due to the increased prevalence of chronic diseases like diabetes, cardiovascular disease, and neurodegenerative disorders. These disorders can be managed and treated with the aid of devices like neuro stimulators, cardiac implants, and insulin pumps. Furthermore, implantable medical devices offer patients a higher quality of life and lessen the stress of ongoing care or frequent hospital visits by delivering a long-lasting and sustainable solution for controlling chronic disorders. These factors expand market demand.
As it might be difficult to make sure that implantable devices are properly integrated with a patient's individual anatomy and medical conditions, device compatibility is a significant barrier in the market for implantable medical devices. Each person has a unique anatomy and physiology. However, due to this variation, implanted medical technology must be customized to meet the unique requirements and traits of each patient. This problem is more obvious when gadgets need to be fitted specifically for a patient or when individualized treatment is needed. Therefore, it is a barrier to market demand.
The COVID-19 pandemic significantly slowed the industry's expansion as demand for implantable medical devices fell and all routine implantable surgeries were suspended in countries with the disease during the pandemic because of the high risk of cross-infection for medical personnel, auxiliaries, and patients undergoing implant procedures. The market for implantable medical devices has suffered as a result of the COVID-19 epidemic.
The metallic segment is estimated to hold the largest share, due to both the expanding desire for minimally invasive surgeries among patients and the increasing number of traffic accidents and trauma cases around the world. Additionally, the rising use of metal implants in orthopaedic operations to offer sturdy support to broken bones or joints is responsible for this market's dominance. Therefore, this market is anticipated to continue expanding as more people throughout the world have arthritis.
The orthopaedic implants segment is anticipated to have lucrative growth during the forecast period. Orthopaedic implants are widely utilized around the world to support broken bones and replace missing bones or joints. The expansion of this market is being boosted by the increasing number of accidents that result in broken bones and damaged joints. Additionally, the prevalence of rheumatoid arthritis is increasing, leading to an increase in elbow joint replacement surgery. As a result, there are currently more orthopaedic procedures being performed, which could spur the development of orthopaedic implants in the years to come.
North America commanded the largest market share during the extrapolated period. Numerous chronic diseases are now more common in North America, and the number of elderly people is rising. Additionally, the availability of an advanced healthcare infrastructure, an increase in the use of minimally invasive procedures, and rising consumer healthcare spending are the key factors anticipated to propel the growth of the regional medical implant market. Furthermore, in the past, growing consumer awareness of the availability of different medical implants among North American residents has greatly aided market expansion.
Asia Pacific is expected to witness profitable growth over the projection period, due to the expansion of the R&D industry, surge in healthcare reforms, improvement in healthcare infrastructure, increase in the number of hospitals with cutting-edge equipment, and technological developments in the field of implants. The vital role that medical devices play in the identification, monitoring and management of several illnesses contributes to an expanding need for them. The region is linked to a number of prominent medical equipment manufacturers and research centers.
Some of the key players in the Implantable Medical Devices Market include: Zimmer Biomet, Stryker, Dentsply Sirona, Terumo Corporation, Medtronic, Johnson & Johnson, Smith & Nephew, Danaher Corporation, Institut Straumann AG, Boston Scientific Corporation, Abbott, Alcon Laboratories, POLYTECH Health & Aesthetics, MicroPort Scientific Corporation, Bausch & Lomb, Cochlear Limited, Advanced Bionics Corporation and Henry Schein, Inc.
In February 2022, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company's CardioMEMS HF System to support the care of more people living with heart failure.
In February 2022, Boston Scientific Corporation announced the completion of its purchase of Baylis Medical Company Inc., a provider of innovative transseptal access solutions as well as guide wires, sheaths, and dilators used in catheter-based left-heart surgeries.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.